Article Text

Download PDFPDF
Incidence of eyelid cancers in Singapore from 1968 to 1995
  1. Sao-Bing Leea,
  2. Seang-Mei Sawb,
  3. Kah-Guan Au Eongc,
  4. Tat-Keong Chanc,
  5. Hin-Peng Leed
  1. aSingapore Eye Research Institute, bDepartment of Community, Occupational and Family Medicine, National University of Singapore, cSingapore Eye Research Institute, dSingapore Cancer Registry
  1. Sao-Bing Lee, Singapore Eye Research Institute, W212, Singapore Polytechnic, 500 Dover Road, Singapore 139651, Republic of Singapore.

Abstract

AIM To describe the epidemiological characteristics of patients with eyelid malignancies seen in all hospitals in Singapore from 1968 to 1995.

METHOD The Singapore Cancer Registry has been collecting epidemiological data of all cancers seen in Singapore since 1968. The data of all cases of Singapore residents with eyelid cancers diagnosed from 1968 to 1995 (ICD-9, sites 172.1 and 173.1) were retrieved for analysis.

RESULTS There were 162 male patients (49.8%) and 163 females (50.2%). The median age at diagnosis was 63 years in males and 66 years in females. The average annual age standardised incidence rate among male Singapore residents was 6.5 per million and 5.5 per million among female Singapore residents. Between 1993 and 1995, the average annual rate for females was 6.8 per million, compared with 3.1 per million between 1968 and 1972. The most common cancer was basal cell carcinoma (84.0%), followed by sebaceous adenocarcinoma (10.2%) and squamous cell carcinoma (3.4%).

CONCLUSION The annual age standardised incidence for male residents has remained relatively stable. The incidence for female residents has shown a steady increase over the past 28 years. The incidence for males is generally higher than that for females. These expanded epidemiological characteristics may serve to provide a foundation to monitor future disease patterns and to promote further research into the aetiology of these cancers.

  • eyelid cancers
  • Singapore

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes